Delisted

No longer trades. Fund positions are valued at its last close, $0.7400 on Sep 8, 2026. View SEC filing

BRNS

BARINTHUS BIOTHERAPEUTICS PL

BRNS·91864C107·US·ADR·Healthcare - Biotechnology-Activist

BRNS (BARINTHUS BIOTHERAPEUTICS PL) is held by 9 institutional investors as of Q2 2026. Top institutional shareholders: M&G Plc ($5.2M), MORGAN STANLEY ($71,837), Baird Financial Group, Inc. ($69,934).

9
Holders
$5.4M
Total Value
50%
Consensus
13F: Insider & Congress: Updated regularly
BRNS

Smart Money Verdict

View all
Loading verdict
Held by 9 funds

Who's Trading

Source dates: Price Sep 8, 2026 · Insiders Sep 9, 2026 · Activists Sep 11, 2026 · Congress none

ActivistOSOxford Science Enterprises plc0.0%Sep 11, 2026
InsiderWRWright RobinDispSep 9, 2026
InsiderHAHammacher AlexDispSep 9, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
5.2M$5.2M0.0%-68.91%
0
Increased
108,843(+4825.0%)$71,8370.0%+10.94%
23
Unchanged
105,961$69,9340.0%-48.07%
0
Decreased
76,754(-35.5%)$50,6580.0%+8.84%
0
Unchanged
37,450$24,7170.0%-29.52%
0
Decreased
25,000(-83.4%)$16,5000.0%-37.77%
0
New
14,819$9,7810.0%+12.12%
24
Unchanged
11,685$7,7120.0%+8.82%
0
New
1,008$6650.0%+12.12%
17
Exited
0(-100.0%)$6,6220.0%-82.11%
0
BRNSBRNSBARINTHUS BIOTHERAPEUTICS PL

Other Healthcare stocks held by institutions

Questions investors ask about BRNS

Who owns BRNS?

9 institutional investors held BRNS on June 30, 2026, led by M&G Plc ($5.2M), MORGAN STANLEY ($71,837) and Baird Financial Group, Inc. ($69,934).

How many hedge funds hold BRNS?

9 institutional investors reported BRNS in their 13F filings for the quarter ended June 30, 2026, $5.4M in all.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used